Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Theravance Biopharma Company Profile (NASDAQ:TBPH)

Consensus Ratings for Theravance Biopharma (NASDAQ:TBPH) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $34.00 (21.30% upside)

Analysts' Ratings History for Theravance Biopharma (NASDAQ:TBPH)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/6/2014Bank of AmericaInitiated CoverageBuy$34.00ViewTweet This Rating  Share This Rating on StockTwits
6/2/2014Robert W. BairdInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
6/2/2014Robert W. BairdInitiated CoverageNeutral$21.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2012 forward)